MIR3680-2

Across TCGA pan-cancer cohorts, MIR3680-2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR3680-2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR3680-2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3680-2 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

STAD, KIRC, and THCA are the cancer types where MIR3680-2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3680-2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Female	All	+0.701	.023	4	view →
KIRC	All	All	+0.081	.009	3	view →
THCA	All	III,IV	−0.188	.033	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR3680-2–STAD

Open the STAD breakdown →